<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    BioLineRx Ltd.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About BioLineRx Ltd.

    BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Philip A. Serlin, CPA, MBA
    • FOUNDED
      2003
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Aurinia Pharmaceuticals Inc

    Aurinia Pharmaceuticals Inc

    Aurinia is a late clinical stage biopharmaceutical company focused on developing a...

    Aurinia is a late clinical stage biopharmaceuti...

    Filing Type:    PU
    GenMark Diagnostics, Inc.

    GenMark Diagnostics, Inc.

    GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular di...

    GenMark Diagnostics (NASDAQ: GNMK) is a leading...

    Filing Type:    PU
    Exact Sciences Corporation

    Exact Sciences Corporation

    Exact Sciences Corp. (NASDAQ: EXAS) is committed to playing a role in the eradicat...

    Exact Sciences Corp. (NASDAQ: EXAS) is committe...

    Filing Type:    PU
    Arcturus Therapeutics Holdings Inc.

    Arcturus Therapeutics Holdings Inc.

    Arcturus Therapeutics is developing portfolio of RNA therapeutics for treatment of...

    Arcturus Therapeutics is developing portfolio o...

    Filing Type:    PU
    Ocular Therapeutix, Inc.

    Ocular Therapeutix, Inc.

    Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on ...

    Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a bi...

    Filing Type:    PU
    Marinus Pharmaceuticals, Inc.

    Marinus Pharmaceuticals, Inc.

    Marinus Pharmaceuticals, Inc. is committed to improving the lives of patients suff...

    Marinus Pharmaceuticals, Inc. is committed to i...

    Filing Type:    PU
    Anixa Biosciences, Inc.

    Anixa Biosciences, Inc.

    Anixa is focused on harnessing the body’s immune system in the fight against can...

    Anixa is focused on harnessing the body’s imm...

    Filing Type:    PU
    Gamida Cell Ltd.

    Gamida Cell Ltd.

    Gamida Cell is a clinical-stage biopharmaceutical company committed to developing ...

    Gamida Cell is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology (“GCT”) is an emerging medical technology company with nu...

    Global Cancer Technology (“GCT”) is an emerging...

    Amount Raised:    $82,711.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2025 National Investor Network. All Rights Reserved.